Browse by author
Lookup NU author(s): Dr Ased Ali
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Prostate cancer is one of the most prevalent malignancies affecting men in the developed world. A spectrum of disease states exists and management is tailored to individual patients. Increasing public awareness and prostate-specific antigen testing have led to earlier detection and the possibility of cure but have increased the risk of overtreatment of indolent disease. Advances in curative modalities have reduced side effects and offer patients a choice of treatments. Nonetheless, many need no intervention and may be safely treated with active monitoring. Choice and timing of therapy for locally advanced and recurrent disease are variable, with potential benefits of early intervention counterbalanced by side effects of treatment. Progress has been made in the management of advanced disease; skeletal-related events have been reduced and survival has been increased. This review examines the evidence and rationale behind the treatment options from curative intent to management of locally advanced disease and palliation of metastatic disease.
Author(s): Ali AS, Hamdy FC
Publication type: Article
Publication status: Published
Journal: Current Urology Reports
Year: 2007
Volume: 8
Issue: 3
Pages: 245-252
Print publication date: 01/05/2007
ISSN (print): 1527-2737
ISSN (electronic): 1534-6285
Publisher: Current Medicine Group
URL: http://dx.doi.org/10.1007/s11934-007-0013-9
DOI: 10.1007/s11934-007-0013-9
PubMed id: 17459275
Altmetrics provided by Altmetric
